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Background
In 2008 artemether-lumefantrine and dihydroartemisinin-
piperaquine were added to amodiaquine - artesunate as
first line drugs for uncomplicated malaria in Ghana. The
introduction of new drugs calls for continuous monitoring
of these drugs to provide timely information on trends of
their efficacy and safety to enhance timely evidence-based
decision making by the National Malaria Control Pro-
gramme. In this regard, we monitored the therapeutic effi-
cacy of artemether - lumefantrine from September 2010 to
April 2011 in 4 sentinel sites representing the 3 main eco-
logical zones of the country.
Materials and methods
The study population involved all children aged between 6
and 59 months presenting at the Out-Patient Department
(OPD) of a study site clinic with symptoms suggestive of
malaria. Using the 2009 WHO protocol for surveillance of
antimalarial drug efficacy, primary outcomes for the study
were treatment outcomes on Day 14 and Day 28 for the
different ecological zones whilst secondary outcomes were
patterns of fever and parasite clearance as well as gameto-
cyte carriage and haematological responses. The Institu-
tional Review Board of the Noguchi Memorial Institute for
Medical Research, University of Ghana, reviewed and
approved the study.
Results
Per-protocol analysis showed that the overall pcr-
corrected cure rates on day 14 and day 28 were 96.5%
(95% CI: 92.1, 98.6) and 95.4% (95% CI: 90.3, 98.0), respec-
tively, with statistically significant differences between the
ecological zones. The 90.4% day-28 cure rate observed in
the savannah zone (95% CI: 78.2, 96.4) was significantly
the lowest compared with 100% (95% CI: 93.2, 99.9) in the
forest zone and 93.8% (95% CI: 77.8, 98.9) in the coastal
zone (P=0.017). Fever and parasite clearance were slower
among children enrolled in the savannah zone. The pro-
portion of children still febrile on day 1 post-treatment
was significantly highest in the savannah zone (42.9%; 95%
CI: 30.0, 56.7) compared with the forest zone (16.7%; 95%
CI: 9.5, 27.2) and the coastal zone (10.5%; 95% CI: 3.4,
25.7) (P=0.000). Additionally, 14.5% (95% CI: 6.9, 27.2) of
the children enrolled in the savannah zone were parasitae-
mic on day 2 post-treatment whilst no child was parasitae-
mic on the same day in the forest and coastal zones.
Gametocytaemia after day 3 post-treatment was rare in all
the zones. Mean haemoglobin concentration significantly
increased only in the forest zone from 10.1g/dl (95% CI:
9.6, 10.5) on day 0 to 11.0g/dl (95% CI: 10.6, 11.4) on day
28 (p=0.004).
Conclusions
We conclude that AL remains efficacious in Ghana with
significant ecologic zonal differences. The savannah zone
may be a potential zone for any emergence of resistant
alleles as a result of the slower parasite clearance observed
in the zone.
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